Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the symbol lookup tool.
Alphabetize the sort order of my symbols
ETFs with ACOR as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.13%||PowerShares Dynamic Biotech &Genome (PBE)||+2.94 (8.12%)|
|1.46%||SPDR Series Trust SPDR S&P Biotech ETF (XBI)||+2.35 (1.91%)|
|0.6%||WisdomTree SmallCap Earnings Fund (EES)||+1.45 (1.84%)|
|0.05%||RevenueShares Small Cap (RWJ)||+1.89 (3.66%)|
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
We are a biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, or MS, spinal cord injury, or SCI, and other disorders of the nervous system. We have marketed as well as developmental stage products and are working to bring important new therapies to people with nervous system disorders. Our goal is to help patients to a better future, while building a leading neurology company with a portfolio of innovative products. The first product for which we completed clinical development, Ampyra (dalfampridine) Extended Release Tablets, 10mg was approved by the U.S. Food and Drug Administration, or FDA, in January 2010 as a treatment to improve walking in patients with MS. This was demonstrated by an increase in walking speed. ... More ...